The company was founded in 2002 in Delaware, USA, and is committed to developing and producing liquid chromatography materials and technology for the separation and purification of drugs such as biomacromolecules. Development and production of liquid chromatography materials for drug analysis, detection and separation and purification. The company's main products are chromatographic columns and chromatographic fillers. According to application, they can be divided into two major fields: analytical chromatography and industrial purification, providing biopharmaceutical companies with separation and purification products and related services throughout the entire cycle from drug research and development, pre-clinical (pre-IND) to clinical phase I, II, and III, production and quality control. The company's shares were listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on January 10, 2025